[1\]Wilson LE,D′Aloisio AA,Sandler DP,et al.Longterm use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women\[J\].Breast Cancer Res,2016,18(1):61.\[2\]张惠灏，朱有志，吴坤琳，等. 高迁移率族蛋白B1在乳腺癌组织中的表达及其临床意义\[J\].中华实验外科杂志，2014，31(12)：2828-2831.\[3\]鲁凯，姚壮凯，刘燕文，等. RAGE和HMGB1在乳腺癌中表达及其临床意义\[J\]. 中国肿瘤外科杂志，2012，4(6)：352-354.\[4\]Yin C, Li H, Zhang B.Erratum to: RAGEbinding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelialmesenchymal transition\[J\].Breast Cancer Res Treat, 2016,156(2):407-408.\[5\]Nasser MW, Ahirwar DK, Ganju RK,et al.RAGE: A novel target for breast cancer growth and metastasis\[J\].Oncoscience, 2016,3(2):52-53.\[6\]Kostova N, Zlateva S, Ugrinova I, et al.The expression of HMGB1 protein and its receptor RAGE in human malignant tumors\[J\].Mol Cell Biochem， 2010,337(1/2):251-258.\[7\]Stoetzer OJ, Fersching DM, Salat C, et al. Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy\[J\].Tumour Biol, 2013, 34(1):81-90.\[8\]曹清心,刘宇,凌昌全. HMGB1与肿瘤相关性的研究进展\[J\].临床肿瘤学杂志, 2012, 17(3): 282-285.\[9\]Zhang X, Song Y, Han X, et al. Liquiritin attenuates advanced glycation end productsinduced endothelial dysfunction via RAGE/NFκB pathway in human umbilical vein endothelial cells\[J\]. Mol Cell Biochem, 2013,374(1/2):191-201.\[10\]Zhang J, Zhu JS, Zhou Z, et al. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1RAGE and Akt pathways in vitro and in vivo\[J\]. Oncol Rep, 2012,27(5):1511-1519.\[11\]张晨光，任峰，王辉，等. HMGB1与其受体分子信号转导通路的研究进展\[J\]. 中国免疫学杂志，2014，30(2)：275-279.
2017, Vol. 27 
